title: Acquired epidermodysplasia verruciformis syndrome in HIV-infected pediatric patients: prospective treatment trial with topical glycolic acid and human papillomavirus genotype characterization.
authors.forename: Rachael L
authors.initials: RL
authors.lastname: Moore
authors.forename: Virginie
authors.initials: V
authors.lastname: de Schaetzen
authors.forename: Marissa
authors.initials: M
authors.lastname: Joseph
authors.forename: Ivy Ann
authors.initials: IA
authors.lastname: Lee
authors.forename: Yvette
authors.initials: Y
authors.lastname: Miller-Monthrope
authors.forename: B Ryan
authors.initials: BR
authors.lastname: Phelps
authors.forename: Shimane S
authors.initials: SS
authors.lastname: Lekalake
authors.forename: Sarah J
authors.initials: SJ
authors.lastname: Ratcliffe
authors.forename: Harrison
authors.initials: H
authors.lastname: Nguyen
authors.forename: Qin
authors.initials: Q
authors.lastname: He
authors.forename: Peter
authors.initials: P
authors.lastname: Rady
authors.forename: Stephen
authors.initials: S
authors.lastname: Tyring
authors.forename: Carrie L
authors.initials: CL
authors.lastname: Kovarik
mesh_terms: D000287:Administration, Topical; D000293:Adolescent; D002648:Child; D004819:Epidermodysplasia Verruciformis / Q000150:complications* / Q000821:virology*; D005260:Female; D005838:Genotype; D006016:Glycolates / Q000008:administration & dosage*; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D008297:Male; D027383:Papillomaviridae / Q000145:classification* / Q000235:genetics*; D011446:Prospective Studies
chemical_list: D006016:Glycolates; C031149:glycolic acid